Amarin Corporation plc, each representing one Ordinary Share (AMRN): Price and Financial Metrics


Amarin Corporation plc, each representing one Ordinary Share (AMRN)

Today's Latest Price: $6.95 USD

0.03 (0.43%)

Updated Jul 6 12:03pm

Add AMRN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

AMRN Stock Summary

  • The price/operating cash flow metric for Amarin Corp Plc is higher than 96.25% of stocks in our set with a positive cash flow.
  • With a year-over-year growth in debt of -43.62%, Amarin Corp Plc's debt growth rate surpasses just 6.24% of about US stocks.
  • As for revenue growth, note that AMRN's revenue has grown 97.8% over the past 12 months; that beats the revenue growth of 94.14% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Amarin Corp Plc are OFIX, QRHC, VG, CRY, and WLDN.
  • AMRN's SEC filings can be seen here. And to visit Amarin Corp Plc's official web site, go to www.amarincorp.com.
AMRN Daily Price Range
AMRN 52-Week Price Range

AMRN Stock Price Chart Technical Analysis Charts


AMRN Price/Volume Stats

Current price $6.95 52-week high $26.12
Prev. close $6.92 52-week low $3.95
Day low $6.87 Volume 1,855,003
Day high $7.04 Avg. volume 11,302,663
50-day MA $7.19 Dividend yield N/A
200-day MA $14.13 Market Cap 2.68B

Amarin Corporation plc, each representing one Ordinary Share (AMRN) Company Bio


Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company was founded in 1989 and is based in Dublin, Ireland.


AMRN Latest News Stream


Event/TimeNews Detail
Loading, please wait...

AMRN Latest Social Stream


Loading social stream, please wait...

View Full AMRN Social Stream

Latest AMRN News From Around the Web

Below are the latest news stories about Amarin Corp Plc that investors may wish to consider to help them evaluate AMRN as an investment opportunity.

Amarin Corporation plc (NASDAQ:AMRN): Is Breakeven Near?

Amarin Corporation plc's (NASDAQ:AMRN): Amarin Corporation plc, a pharmaceutical company, develops and commercializes...

Yahoo | July 3, 2020

Amarin (AMRN) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Amarin (AMRN) closed at $7.03, marking a +1.59% move from the previous day.

Yahoo | July 1, 2020

Implied Volatility Surging for Amarin (AMRN) Stock Options

Investors need to pay close attention to Amarin (AMRN) stock based on the movements in the options market lately.

Yahoo | June 30, 2020

Amarin (AMRN) Gains But Lags Market: What You Should Know

In the latest trading session, Amarin (AMRN) closed at $6.92, marking a +0.58% move from the previous day.

Yahoo | June 25, 2020

Amarin (AMRN) stock to remain within a tight range until the end of Vascepa litigation

The patent war between Amarin (NASDAQ: AMRN) and the generic companies for cardiovascular drug Vascepa continues to be a headwind for Amarin. Shares of the clinical biotechnology company were shattered at the end of March after the Nevada Court ruled in favor of two generic companies in the patent litigation case related to the generic […]

News Alphastreet | June 24, 2020

Read More 'AMRN' Stories Here

AMRN Price Returns

1-mo 4.04%
3-mo 37.90%
6-mo -64.29%
1-year -69.99%
3-year 68.69%
5-year 206.17%
YTD -67.58%
2019 57.53%
2018 239.40%
2017 30.19%
2016 62.96%
2015 92.86%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 1.0906 seconds.